Researchers implicated heat shock protein 27 as a marker of advanced pathogenesis of disease contributing to the dysregulated systemic inflammation and worse clinical outcomes in COVID-19 acute respiratory distress syndrome and therefore may represent a potential therapeutic target.
[Cell Stress & Chaperones]
